APA (7th ed.) Citation

Potthoff, K., Habl, G., Bruckner, T., Suppan, C., Hassel, J. C., Jäger, D., & Debus, J. (2016). Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: The support trial. BioMed Central.

Chicago Style (17th ed.) Citation

Potthoff, Karin, Gregor Habl, Thomas Bruckner, Christian Suppan, Jessica C. Hassel, Dirk Jäger, and Jürgen Debus. Randomized Controlled Trial to Evaluate the Effects of Ethyl-2-cyanoacrylate on Pain Intensity and Quality of Life in Head and Neck Cancer Patients Suffering from Cetuximab-induced Rhagades During Radioimmunotherapy: The Support Trial. London: BioMed Central, 2016.

MLA (9th ed.) Citation

Potthoff, Karin, et al. Randomized Controlled Trial to Evaluate the Effects of Ethyl-2-cyanoacrylate on Pain Intensity and Quality of Life in Head and Neck Cancer Patients Suffering from Cetuximab-induced Rhagades During Radioimmunotherapy: The Support Trial. BioMed Central, 2016.